Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 10-2008 | 10-2007 | 12-2006 | 10-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 535,500 | 631,400 | 520,200 | N/A | 142,200 |
| Marketable Securities | N/A | N/A | 61,600 | N/A | 395,400 |
| Receivables | 197,600 | 240,600 | 204,100 | N/A | 193,100 |
| Inventories | 124,600 | 162,700 | 169,600 | N/A | 165,400 |
| Other current assets | 9,800 | 8,000 | 20,800 | 0 | 15,100 |
| TOTAL | $900,800 | $1,077,400 | $1,008,200 | $N/A | $942,700 |
| Non-Current Assets | |||||
| PPE Net | 162,800 | 177,100 | 198,100 | N/A | 206,400 |
| Investments And Advances | 0 | 0 | 113,800 | 0 | 10,700 |
| Intangibles | 93,500 | 520,400 | 360,300 | 0 | 380,500 |
| Other Non-Current Assets | 186,500 | 146,100 | 84,400 | 0 | 71,100 |
| TOTAL | $442,800 | $843,600 | $756,600 | $N/A | $668,700 |
| Total Assets | $1,343,600 | $1,921,000 | $1,764,800 | $N/A | $1,611,400 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 83,000 | 99,100 | 89,000 | 0 | 88,200 |
| Accrued Expenses | 80,300 | 94,800 | 97,200 | N/A | 75,000 |
| TOTAL | $236,100 | $278,000 | $474,100 | $N/A | $263,900 |
| Non-Current Liabilities | |||||
| Long Term Debt | 651,000 | 650,700 | 200,600 | N/A | 400,000 |
| Other Non-Current Liabilities | 96,900 | 78,800 | 82,500 | 0 | 74,000 |
| TOTAL | $746,600 | $728,800 | $283,100 | $N/A | $474,000 |
| Total Liabilities | $982,700 | $1,006,800 | $757,200 | $N/A | $737,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,626 | 96,447 | 117,582 | N/A | 117,264 |
| Common Shares | 23,600 | 23,500 | 23,500 | N/A | 23,500 |
| Retained earnings | -965,900 | -491,500 | -450,900 | N/A | -557,200 |
| Other shareholders' equity | -8,700 | -14,100 | 2,700 | 0 | -10,200 |
| TOTAL | $360,900 | $914,200 | $1,007,600 | $N/A | $873,500 |
| Total Liabilities And Equity | $1,343,600 | $1,921,000 | $1,764,800 | $0 | $1,611,400 |